Amwell (AMWL) Tops Q4 EPS by 9c

Amwell (NYSE: AMWL) reported Q4 EPS of ($0.18), $0.09 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $72.8 million versus the consensus estimate of $69.07 million.

GUIDANCE:

Amwell sees FY2022 revenue of $275-285 million, versus the consensus of $312 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.

You May Also Be Interested In

• Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
• Academy Sports surges on earnings beat and raised guidance
• Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance